Concert Pharmaceuticals Releases Information on Upcoming CTP-543 Phase 3 Trials
Leading off of the Phase 2 CTP-543 trials, Chief Development Officer of Concert Pharmaceuticals, Dr. James V. Cassella states: “The planned initiation
Edmonton Support Group Meetings Cancelled Until Further Notice
With the recent developments regarding the spread of the COVID-19, the Edmonton Alopecia Support Group will be postponing all events for the
Important Notice: COVID-19
In response to the spread of the COVID-19 virus in Canada, CANAAF is actively discussing alternative options and additional precautionary measures for